Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PTGDR2 | Q9Y5Y4 | 4/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | IDO1 | P14902 | 1/20 | 0.39 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.38 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MIF | P14174 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19838624 | 1.00 | CYP1A2 (0.44) | CYP1A2PTGDR2POLBIDO1SIGMAR1 | |
| SCHEMBL29960447 | 0.87 | CYP1A2 (0.42) | CYP1A2POLBIDO1SIGMAR1KCNH2 | |
| SCHEMBL19984866 | 0.81 | CYP1A2 (0.49) | CYP1A2POLBIDO1SIGMAR1KCNH2 | |
| SCHEMBL15056539 | 0.80 | PPARD (0.42) | PTGDR2L3MBTL1 | |
| SCHEMBL29960678 | 0.80 | PPARD (0.42) | PTGDR2L3MBTL1 | |
| SCHEMBL30618514 | 0.79 | CYP1A2 (0.47) | CYP1A2IDO1NOTUM | |
| SCHEMBL3348647 | 0.79 | CYP1A2 (0.47) | CYP1A2IDO1NOTUM | |
| SCHEMBL3349544 | 0.78 | L3MBTL1 (0.49) | CYP1A2POLBL3MBTL1TSHRHSD17B10 | |
| SCHEMBL21199909 | 0.78 | CYP1A2 (0.46) | CYP1A2POLBIDO1SIGMAR1KCNH2 | |
| SCHEMBL5468751 | 0.77 | ALDH1A1 (0.49) | CYP1A2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022204150-A1 | COMPOUNDS AND COMPOSITIONS FOR TREATING CNS DISORDERS | BLUE OAK PHARMACEUTICALS, INC. (US) | 2022-09-29 | — | — | WO | disclosed |